Cargando…

Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate

BACKGROUND AND OBJECTIVES: Nontypeable Haemophilus influenzae (NTHi) are major causes of non-invasive infections, including otitis media and sinusitis and it can also contribute to respiratory infections of all ages. Currently, there is no licensed vaccine against NTHi commercially available. Many s...

Descripción completa

Detalles Bibliográficos
Autores principales: Behrouzi, Ava, Mianroodi, Reza Arabi, Afrough, Parviz, Ayadi, Ahmad, Serajian, Amirarsalan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867700/
https://www.ncbi.nlm.nih.gov/pubmed/33603996
http://dx.doi.org/10.18502/ijm.v12i5.4602
_version_ 1783648328991375360
author Behrouzi, Ava
Mianroodi, Reza Arabi
Afrough, Parviz
Ayadi, Ahmad
Serajian, Amirarsalan
author_facet Behrouzi, Ava
Mianroodi, Reza Arabi
Afrough, Parviz
Ayadi, Ahmad
Serajian, Amirarsalan
author_sort Behrouzi, Ava
collection PubMed
description BACKGROUND AND OBJECTIVES: Nontypeable Haemophilus influenzae (NTHi) are major causes of non-invasive infections, including otitis media and sinusitis and it can also contribute to respiratory infections of all ages. Currently, there is no licensed vaccine against NTHi commercially available. Many studies have been conducted on the use of OMV as a vaccine against NTHi. The purpose of this study is to achieve an immunogenic vaccine against NTHi. MATERIALS AND METHODS: In this study, standard OMV Haemophilus (ATCC49766) with adjuncts CpG and MPLA was used and after infusion into BALB/c mice, the levels of antibodies and cytokines were measured on serum of immunized mice. RESULTS: The results showed that total IgG antibody and IgG1 and IgG2a isotypes in OMV immunized mice with mixture of CpG-MPLA adjuvant had a significant increase. Also, the results of cytokines (IL-10, IL-4 and IFN-γ) showed that IL-4 had the highest rate. CONCLUSION: These findings indicate that OMVs derived from NTHi strains have a high potential to act as a vaccine against NTHi infections.
format Online
Article
Text
id pubmed-7867700
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-78677002021-02-17 Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate Behrouzi, Ava Mianroodi, Reza Arabi Afrough, Parviz Ayadi, Ahmad Serajian, Amirarsalan Iran J Microbiol Original Article BACKGROUND AND OBJECTIVES: Nontypeable Haemophilus influenzae (NTHi) are major causes of non-invasive infections, including otitis media and sinusitis and it can also contribute to respiratory infections of all ages. Currently, there is no licensed vaccine against NTHi commercially available. Many studies have been conducted on the use of OMV as a vaccine against NTHi. The purpose of this study is to achieve an immunogenic vaccine against NTHi. MATERIALS AND METHODS: In this study, standard OMV Haemophilus (ATCC49766) with adjuncts CpG and MPLA was used and after infusion into BALB/c mice, the levels of antibodies and cytokines were measured on serum of immunized mice. RESULTS: The results showed that total IgG antibody and IgG1 and IgG2a isotypes in OMV immunized mice with mixture of CpG-MPLA adjuvant had a significant increase. Also, the results of cytokines (IL-10, IL-4 and IFN-γ) showed that IL-4 had the highest rate. CONCLUSION: These findings indicate that OMVs derived from NTHi strains have a high potential to act as a vaccine against NTHi infections. Tehran University of Medical Sciences 2020-10 /pmc/articles/PMC7867700/ /pubmed/33603996 http://dx.doi.org/10.18502/ijm.v12i5.4602 Text en Copyright© 2020 The Authors. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license, (https://creativecommons.org/licenses/by-nc/4.0/) Non-commercial uses of the work are permitted, provided the original work is properly cited.
spellingShingle Original Article
Behrouzi, Ava
Mianroodi, Reza Arabi
Afrough, Parviz
Ayadi, Ahmad
Serajian, Amirarsalan
Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate
title Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate
title_full Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate
title_fullStr Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate
title_full_unstemmed Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate
title_short Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate
title_sort evaluation of immunological responses against outer membrane vesicles (omv) of nontypeable haemophilus influenzae using mpla-cpg adjuvant as a vaccine candidate
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867700/
https://www.ncbi.nlm.nih.gov/pubmed/33603996
http://dx.doi.org/10.18502/ijm.v12i5.4602
work_keys_str_mv AT behrouziava evaluationofimmunologicalresponsesagainstoutermembranevesiclesomvofnontypeablehaemophilusinfluenzaeusingmplacpgadjuvantasavaccinecandidate
AT mianroodirezaarabi evaluationofimmunologicalresponsesagainstoutermembranevesiclesomvofnontypeablehaemophilusinfluenzaeusingmplacpgadjuvantasavaccinecandidate
AT afroughparviz evaluationofimmunologicalresponsesagainstoutermembranevesiclesomvofnontypeablehaemophilusinfluenzaeusingmplacpgadjuvantasavaccinecandidate
AT ayadiahmad evaluationofimmunologicalresponsesagainstoutermembranevesiclesomvofnontypeablehaemophilusinfluenzaeusingmplacpgadjuvantasavaccinecandidate
AT serajianamirarsalan evaluationofimmunologicalresponsesagainstoutermembranevesiclesomvofnontypeablehaemophilusinfluenzaeusingmplacpgadjuvantasavaccinecandidate